Modulname:
NEO-KISS
Kurzname:
NEO
Surveillance objective:
Infection Surveillance, Pathogen Surveillance, and Antibiotic Surveillance
Surveillance principle:
Patient-based (included patients are tracked throughout the entire neonatal department)
Patient collective:
  • Stationary patients
Short description:
Recording of Nosocomial Infections, Multidrug-Resistant Pathogens, and Antibiotic Use in Premature Infants with a Birth Weight < 1,500 g in Neonatal Departments
Detail description:
NEO-KISS Module (Surveillance System for Nosocomial Infections, Multidrug-Resistant Pathogens, and Antibiotic Use in Premature Infants in Neonatal Departments) Worldwide, infections are one of the main causes of neonatal mortality and morbidity. Advances in neonatal intensive care have significantly reduced mortality in very low birth weight preterm infants; however, these infants are at high risk of developing nosocomial infections. Surveillance has proven to be an effective method for reducing nosocomial infections, with a key component being the comparison of infection rates. National comparison data are essential for evaluating infection rates and assessing the effectiveness of preventive measures. NEO-KISS is a surveillance system for nosocomial infections, multidrug-resistant pathogens, and antibiotic use in premature infants in neonatal intensive care units. The project aims to support neonatal surveillance and provide national reference data for benchmarking. The project began in May 1999 as a pilot and has collected patient-based data since January 2000. Included are all infants with a birth weight (BW) under 1,500 g until discharge, death, or >1,800 g. For diagnosing the three types of infections to be recorded (pneumonia, primary sepsis, and necrotizing enterocolitis (NEC)), specifically developed definitions are used. Stratified incidence densities by BW classes (<500 g, 501–999 g, and 1,000–1,499 g), device-associated infection rates per 1,000 device days (e.g., ventilation or vascular catheters), and antibiotic usage density (treatment days/1,000 patient days) are calculated. Additionally, the occurrence of community-acquired and nosocomial cases of multidrug-resistant pathogens is recorded and analyzed in various rates as described in the surveillance protocol. The data required for NEO-KISS are entered by participants into the webKess interface, where they are immediately available for analysis. Once a year, the current reference data are calculated from the data entered in webKess. To participate in NEO-KISS, participants must complete an introductory course where the method is thoroughly explained, and the application of diagnostic definitions is practiced. If you are interested in participating in NEO-KISS, you must first register for an introductory course. The date for the next course will be announced in a timely manner on our homepage under "Current."